Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (1-10 of 936) with videos related to

Pageof 94
Sort By:
Brain : a Journal of Neurology|April 1, 2010
Angiogenesis in glioblastoma: just another moving target?Michael Weller
Neuro-Oncology|March 24, 2010
Immunotherapy for glioblastoma: a long and winding roadMichael Weller
Krankenpflege Journal|November 6, 2004
[Changes in survival by combined radio-chemotherapy]Michael Weller
Neuro-Oncology|June 22, 2013
Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma?Michael Weller
European Journal of Cancer (Oxford, England : 1990)|April 16, 2018
Next generation neuro-oncologyMichael Weller
Cancer|January 31, 2018
Where does O<sup>6</sup> -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?Michael Weller
Neuro-Oncology|June 4, 2011
Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trialsMichael Weller
Neuro-Oncology Practice|August 9, 2020
Important themes in <i>Neuro-Oncology Practice</i>: Rare brain tumors, radiotherapy and its side effects, and supportive and palliative careMichael Weller
Neuro-Oncology Practice|September 27, 2019
Challenges in the diagnoses and treatment of CNS tumorsMichael Weller
Neuro-Oncology|August 2, 2012
Microglia: a novel treatment target in gliomasMichael Weller
Pageof 94

Showing results (1-10 of 936) with videos related to

Sort By:
Pageof 94
Brain : a Journal of Neurology|April 1, 2010
Angiogenesis in glioblastoma: just another moving target?Michael Weller
Neuro-Oncology|March 24, 2010
Immunotherapy for glioblastoma: a long and winding roadMichael Weller
Krankenpflege Journal|November 6, 2004
[Changes in survival by combined radio-chemotherapy]Michael Weller
Neuro-Oncology|June 22, 2013
Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma?Michael Weller
European Journal of Cancer (Oxford, England : 1990)|April 16, 2018
Next generation neuro-oncologyMichael Weller
Cancer|January 31, 2018
Where does O<sup>6</sup> -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?Michael Weller
Neuro-Oncology|June 4, 2011
Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trialsMichael Weller
Neuro-Oncology Practice|August 9, 2020
Important themes in <i>Neuro-Oncology Practice</i>: Rare brain tumors, radiotherapy and its side effects, and supportive and palliative careMichael Weller
Neuro-Oncology Practice|September 27, 2019
Challenges in the diagnoses and treatment of CNS tumorsMichael Weller
Neuro-Oncology|August 2, 2012
Microglia: a novel treatment target in gliomasMichael Weller
Pageof 94